Comment on Bezin et al. GLP-1 Receptor Agonists and the Risk of Thyroid Cancer. Diabetes Care 2023;46:384–390
Mayumi Endo(University of Washington), Irl B. Hirsch(University of Washington), Tracy S. Tylee(University of Washington), Anthony J. DeSantis(University of Washington), Mara Y. Roth(University of Washington)
Cited by 5
Related Papers
Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range
|Diabetes Care|2019|3.8k
International Consensus on Use of Continuous Glucose Monitoring
|Diabetes Care|2017|2k
American Association of Clinical Endocrinologists and American Diabetes Association Consensus Statement on Inpatient Glycemic Control
|Diabetes Care|2009|1.5k